Cognitive functioning following one-year natalizumab treatment: A non-randomized clinical trial.

Ia RorsmanC PetersenP C Nilsson

Published in: Acta neurologica Scandinavica (2017)

The results demonstrate improvement in information processing speed following 12-months of natalizumab treatment. The results are interpreted as reflection of anti-inflammatory properties of natalizumab rather than retest- or long-term restorative effects.

Keyphrases

multiple sclerosis
anti inflammatory
clinical trial
healthcare
social media
smoking cessation